A
Alan W. Hemming
Researcher at University of California, San Diego
Publications - 171
Citations - 7968
Alan W. Hemming is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 49, co-authored 169 publications receiving 7424 citations. Previous affiliations of Alan W. Hemming include University of Florida & University of Toronto.
Papers
More filters
Journal ArticleDOI
Preoperative Portal Vein Embolization for Extended Hepatectomy
Alan W. Hemming,Alan I. Reed,Richard J. Howard,Shiro Fujita,Steven N. Hochwald,James G. Caridi,Irvin F. Hawkins,Jean Nicolas Vauthey +7 more
TL;DR: Preoperative PVE is a safe and effective method of increasing the remnant liver volume in patients with estimated postresection volumes of less than 25% appears to reduce postoperative liver dysfunction.
Journal ArticleDOI
Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shimul A. Shah,Sean P. Cleary,Alice C. Wei,Ilun Yang,Bryce R. Taylor,Alan W. Hemming,Bernard Langer,David R. Grant,Paul D. Greig,Steven Gallinger +9 more
TL;DR: Despite recurrences in >50% of patients, long-term survival can be achieved after resection of HCC, and intermediate and poor tumor differentiation and tumor size and number were significant predictors of disease-free survival.
Journal ArticleDOI
Surgical management of hilar cholangiocarcinoma.
TL;DR: Combined liver and bile-duct resection can be performed for hilar cholangiocarcinoma with acceptable mortality, though higher than that for liver resection performed for other indications, as well as the use of PVE in cases where hypertrophy of the remnant liver has not occurred preoperatively.
Journal ArticleDOI
Liver transplantation for hepatocellular carcinoma.
Alan W. Hemming,Mark S. Cattral,Alan I. Reed,Willem J. Van der Werf,Paul D. Greig,Richard J. Howard +5 more
TL;DR: In this article, the authors analyzed patient and tumor characteristics that influence patient survival to select patients who would most benefit from liver transplantation, and found that vascular invasion, tumor size greater than 5 cm, and poorly differentiated tumor grade were predictors of tumor recurrence.
Journal ArticleDOI
Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients.
Alan W. Hemming,Charles H. Scudamore,Christopher R. Shackleton,Morris R. Pudek,Sigfried R. Erb +4 more
TL;DR: Twenty-two cirrhotic patients who underwent hepatic resection from July 1989 to March 1991 at Vancouver General Hospital were analyzed prospectively to determine whether there was any preoperative evaluation of liver function that would help identify those patients who would not survive resection.